Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Broggini

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Vaccines|November 18, 2020
Anti-Influenza Effect of Nanosilver in a Mouse ModelIrina V Kiseleva, Mohammad Al Farroukh, Ekaterina A Skomorokhova, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 23, 2019
Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growthOuma Cisse, Muzthahid Quraishi, Federico Gulluni, et al.
Cancer Research|September 17, 2005
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effectsTania Maffucci, Enza Piccolo, Albana Cumashi, et al.
Oncotarget|March 3, 2016
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progressionAnissa Chikh, Riccardo Ferro, Jonathan J Abbott, et al.
Cancers|July 29, 2020
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to ChemotherapyAikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, et al.
Chemmedchem|November 21, 2018
Structure-Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFRLuca Carlino, Michael S Christodoulou, Valentina Restelli, et al.
Frontiers in Immunology|May 25, 2023
Exploiting endocytosis for transfection of mRNA for cytoplasmatic delivery using cationic gold nanoparticlesMuriel F Gustà, Michael J Edel, Vivian A Salazar, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 2, 2024
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapyGloriana Ndembe, Ilenia Intini, Massimo Moro, et al.
Plos One|January 12, 2016
Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell LinesSarah Franco Vieira de Oliveira, Monica Ganzinelli, Rosaria Chilà, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 22, 2021
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based TreatmentsCristina Borzi, Monica Ganzinelli, Elisa Caiola, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Vaccines|November 18, 2020
Anti-Influenza Effect of Nanosilver in a Mouse ModelIrina V Kiseleva, Mohammad Al Farroukh, Ekaterina A Skomorokhova, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 23, 2019
Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growthOuma Cisse, Muzthahid Quraishi, Federico Gulluni, et al.
Cancer Research|September 17, 2005
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effectsTania Maffucci, Enza Piccolo, Albana Cumashi, et al.
Oncotarget|March 3, 2016
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progressionAnissa Chikh, Riccardo Ferro, Jonathan J Abbott, et al.
Cancers|July 29, 2020
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to ChemotherapyAikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, et al.
Chemmedchem|November 21, 2018
Structure-Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFRLuca Carlino, Michael S Christodoulou, Valentina Restelli, et al.
Frontiers in Immunology|May 25, 2023
Exploiting endocytosis for transfection of mRNA for cytoplasmatic delivery using cationic gold nanoparticlesMuriel F Gustà, Michael J Edel, Vivian A Salazar, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 2, 2024
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapyGloriana Ndembe, Ilenia Intini, Massimo Moro, et al.
Plos One|January 12, 2016
Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell LinesSarah Franco Vieira de Oliveira, Monica Ganzinelli, Rosaria Chilà, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 22, 2021
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based TreatmentsCristina Borzi, Monica Ganzinelli, Elisa Caiola, et al.
Pageof 12